申聯生物(688098.SH):口蹄疫細胞懸浮培養滅活疫苗生產線、口蹄疫合成肽疫苗生產線通過獸藥GMP驗收
格隆匯5月31日丨申聯生物(688098.SH)公佈,公司蘭州分公司("蘭州分公司")口蹄疫細胞懸浮培養滅活疫苗生產線、口蹄疫合成肽疫苗生產線通過了獸藥GMP驗收,於近日收到甘肅省畜牧獸醫局核發的《獸藥GMP證書》和《獸藥生產許可證》。
口蹄疫合成肽疫苗尚未取得產品批准文號,待取得產品批准文號及相關產品獲批簽發後方可上市銷售,具體上市銷售時間存在不確定性。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.